IP Library Granted Patent US 7,101,535
Granted Patent B2
US 7,101,535 · App. 10/250,631 · Granted Sep 5, 2006

Oral compositions against halitosis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,535
App. No.
10/250,631
Granted
Sep 5, 2006
Kind
B2
Abstract

Disclosed is an oral composition effective against halitosis comprising an extract from Moutan ( Paeonia suffruticosa Andrews) bark as an active ingredient, which is capable of inhibiting and eliminating substances causing oral malodor. The oral composition of the invention compromises an extract from Moutan bark, a medicinal herb, as an active ingredient, formulated in conjunction with to a conventional oral composition, thereby providing long lasting and powerful eliminating and preventive effects against halitosis.

Claims (4)

1. An oral composition effective against halitosis comprising 0.005 to 2 percent by weight, based on the total weight of the composition, of an ethylacetate fraction of an extract from Moutan bark as an active ingredient, wherein the ethylacetate fraction is obtained by suspending the extract in water and then solvent fractionating the suspension with n-hexane, dichloromethane, and ethylacetate in sequential order.

2. An oral composition effective against halitosis comprising 0.005 to 2 percent by weight, based on the total weight of the composition, of an ethylacetate fraction of an extract from Moutan bark as an active ingredient, wherein the ethylacetate fraction is obtained by extracting Moutan bark with n-hexane and then extracting the residual Moutan bark with ethylacetate.

3. The oral composition as set forth in claim 1 , wherein the ethylacetate fraction is present in an amount of 0.01 to 2 percent by weight.

4. The oral composition as set forth in claim 2 , wherein the ethylacetate fraction is present in an amount of 0.01 to 2 percent by weight.

Assignments (2)
SECURITY INTEREST Recorded Aug 8, 2025
From: BALBIX, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 071971/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2003
From: PARK, SANG-KI; KIM, SANG-NYUN; PARK, HYOUNG-KOOK; KIM, MOON-MOO
To: LG HOUSEHOLD & HEALTH CARE LTD.
Reel/Frame 014594/0261 →